719
Views
15
CrossRef citations to date
0
Altmetric
Original

GPCR-induced dissociation of G-protein subunits in early stage signal transduction

, , &
Pages 507-517 | Received 25 Apr 2005, Published online: 09 Jul 2009

Figures & data

Figure 1.  Reconstitution of α2A-AR with (A), Gαi1his + Gβ1γ2 or (B), Gαi1+Gβ1γ2his in suspension. G-protein subunits (20 nM) were combined with 0.1 mg/ml of α2A-AR membranes, 5 µM GDP, 10 µM AMP-PNP (‘reconstitution mix’), 0.2 nM [35S]GTPγS and 100 µM yohimbine (where shown) in TMND buffer. The reaction was started by addition of UK14304 (10 µM final concentration). The reaction was incubated for 90 min at 27°C with shaking. The final volume was 100 µl and the entire reaction mix was filtered over a GF/C filter and washed with 3×4 ml with ice-cold TMN buffer (n=3, mean±SEM). Abbreviations; UK, UK14304, Yoh, yohimbine.

Figure 1.  Reconstitution of α2A-AR with (A), Gαi1his + Gβ1γ2 or (B), Gαi1+Gβ1γ2his in suspension. G-protein subunits (20 nM) were combined with 0.1 mg/ml of α2A-AR membranes, 5 µM GDP, 10 µM AMP-PNP (‘reconstitution mix’), 0.2 nM [35S]GTPγS and 100 µM yohimbine (where shown) in TMND buffer. The reaction was started by addition of UK14304 (10 µM final concentration). The reaction was incubated for 90 min at 27°C with shaking. The final volume was 100 µl and the entire reaction mix was filtered over a GF/C filter and washed with 3×4 ml with ice-cold TMN buffer (n=3, mean±SEM). Abbreviations; UK, UK14304, Yoh, yohimbine.

Figure 2.  Ni2 + -bead capture of α2A-AR-activated [35S]GTPγS:Gαi1his. 20 nM of both Gαi1his and Gβ1γ2 were combined with 0.1 mg/ml of α2A-AR membranes and 5 µM GDP and 10 µM AMP-PNP (‘reconstitution mix’), 0.2 nM [35S]GTPγS, in TMND buffer. Various volumes of Ni(NTA) agarose beads were added to the reconstitution mix as indicated, in the absence (○) or presence () of 10 µM UK14304 [final]. The mix was incubated for 90 min at 27°C with shaking. Final volume was 100 µl. The entire reaction was filtered over a Whatman #1 filter paper and washed with 3×4 ml with ice-cold TMN buffer. A representative experiment is shown.

Figure 2.  Ni2 + -bead capture of α2A-AR-activated [35S]GTPγS:Gαi1his. 20 nM of both Gαi1his and Gβ1γ2 were combined with 0.1 mg/ml of α2A-AR membranes and 5 µM GDP and 10 µM AMP-PNP (‘reconstitution mix’), 0.2 nM [35S]GTPγS, in TMND buffer. Various volumes of Ni(NTA) agarose beads were added to the reconstitution mix as indicated, in the absence (○) or presence (•) of 10 µM UK14304 [final]. The mix was incubated for 90 min at 27°C with shaking. Final volume was 100 µl. The entire reaction was filtered over a Whatman #1 filter paper and washed with 3×4 ml with ice-cold TMN buffer. A representative experiment is shown.

Figure 3.  Agonist dose–response curves with and without Ni2 + -beads. Various concentrations of UK14304 were incubated with 0.2 mg/ml α2A-AR containing reconstituted Gαi1his (50 nM) and β1γ2 (50 nM), 5 µM GDP; 10 µM AMP-PNP and 0.2 nM [35S]GTPγS in the absence (□) or presence (▪) of 10 µl Ni(NTA) agarose beads and the basal binding was 40 and 42 fmol/mg, respectively, whilst the maximal (UK14304-stimulated) binding was 300 and 275 fmol/mg, respectively. Data are presented as percent of maximum bound. The mix was incubated for 90 min at 27°C with shaking. Final volume was 100 µl and the entire reaction was filtered over a Whatman #1 filter and washed with 3×4 ml with ice-cold TMN buffer. The EC50 values were 24 nM and 11 nM in the absence and presence of Ni(NTA) agarose beads, respectively. A representative experiment is shown.

Figure 3.  Agonist dose–response curves with and without Ni2 + -beads. Various concentrations of UK14304 were incubated with 0.2 mg/ml α2A-AR containing reconstituted Gαi1his (50 nM) and β1γ2 (50 nM), 5 µM GDP; 10 µM AMP-PNP and 0.2 nM [35S]GTPγS in the absence (□) or presence (▪) of 10 µl Ni(NTA) agarose beads and the basal binding was 40 and 42 fmol/mg, respectively, whilst the maximal (UK14304-stimulated) binding was 300 and 275 fmol/mg, respectively. Data are presented as percent of maximum bound. The mix was incubated for 90 min at 27°C with shaking. Final volume was 100 µl and the entire reaction was filtered over a Whatman #1 filter and washed with 3×4 ml with ice-cold TMN buffer. The EC50 values were 24 nM and 11 nM in the absence and presence of Ni(NTA) agarose beads, respectively. A representative experiment is shown.

Figure 4.  Antagonist competition curves. To determine IC50 values at the α2A-AR, the following adrenergic receptor subtype-specific antagonists were used: rauwolscine (), yohimbine (○), prazosin (▪) or propranolol (□) as indicated. (A) Direct receptor binding of [3H]MK912 (1 nM) with various concentrations of different adrenergic receptor subtype-specific antagonists as indicated. The reaction mix was filtered over GF/C filters and washed with 3×4 ml with ice-cold TMN buffer. The calculated IC50 values for rauwolscine, yohimbine, prazosin or propranolol for the α2A-AR membrane preparation were 0.091 µM, 0.141 µM, ≈73 µM and ≈275 µM, respectively. (B) Receptor-stimulated binding of [35S]GTPγS in the presence of UK14304 and the indicated amounts of selected antagonists. The experiment was carried out using 20 nM of both Gαi1his and Gβ1γ2 combined with 0.1 mg/ml of α2A-AR membranes, 5 µM GDP and 10 µM AMP-PNP (‘reconstitution mix’), 0.2 nM [35S]GTPγS in the presence of various concentrations of the different adrenergic receptor subtype-specific antagonists as indicated and 10 µl Ni(NTA) agarose beads (n=3, mean±SEM). UK14304 (1 µM final concentration) was added to start the reactions and the mix was incubated for 90 min at 27°C with shaking. Final volume was 100 µl and the entire reaction was filtered over a Whatman #1 filter and washed with 3×4 ml with ice-cold TMN buffer. The IC50 values for each of the antagonists was determined as 0.051 µM (rauwolscine: selective α2-AR antagonist); 0.080 µM (yohimbine: selective α2-AR antagonist); 8.3 µM (prazosin: selective α1-AR antagonist) and 86.9 µM (propranolol: β-AR antagonist).

Figure 4.  Antagonist competition curves. To determine IC50 values at the α2A-AR, the following adrenergic receptor subtype-specific antagonists were used: rauwolscine (•), yohimbine (○), prazosin (▪) or propranolol (□) as indicated. (A) Direct receptor binding of [3H]MK912 (1 nM) with various concentrations of different adrenergic receptor subtype-specific antagonists as indicated. The reaction mix was filtered over GF/C filters and washed with 3×4 ml with ice-cold TMN buffer. The calculated IC50 values for rauwolscine, yohimbine, prazosin or propranolol for the α2A-AR membrane preparation were 0.091 µM, 0.141 µM, ≈73 µM and ≈275 µM, respectively. (B) Receptor-stimulated binding of [35S]GTPγS in the presence of UK14304 and the indicated amounts of selected antagonists. The experiment was carried out using 20 nM of both Gαi1his and Gβ1γ2 combined with 0.1 mg/ml of α2A-AR membranes, 5 µM GDP and 10 µM AMP-PNP (‘reconstitution mix’), 0.2 nM [35S]GTPγS in the presence of various concentrations of the different adrenergic receptor subtype-specific antagonists as indicated and 10 µl Ni(NTA) agarose beads (n=3, mean±SEM). UK14304 (1 µM final concentration) was added to start the reactions and the mix was incubated for 90 min at 27°C with shaking. Final volume was 100 µl and the entire reaction was filtered over a Whatman #1 filter and washed with 3×4 ml with ice-cold TMN buffer. The IC50 values for each of the antagonists was determined as 0.051 µM (rauwolscine: selective α2-AR antagonist); 0.080 µM (yohimbine: selective α2-AR antagonist); 8.3 µM (prazosin: selective α1-AR antagonist) and 86.9 µM (propranolol: β-AR antagonist).

Table I.  Demonstration of his-tag specific capture of G-proteins on Ni2 + -beads. Purified samples of (50 nM) Gαi1, Gαi1his, β1γ2his, Gαi1hisβ1γ2 or Gαi1β1γ2his were incubated with 5 nM [35S]GTPγS in the absence or presence of Ni(NTA) beads (±200 mM imidazole) for 90 min at 27°C. The samples were then filtered over a filter paper stack as described in Materials and Methods, and depicted in . Each filter was counted by liquid scintillation counting separately and the results are shown (in the table, ‘–’ indicates negligible binding associated with the filter, whereas ‘ + ’ indicates significant binding was associated with that filter, by measurement of radioactivity). The Whatman #1 ‘Paper’ filters retain the relatively large (approximately 45–165 µm diameter) Ni(NTA) beads and associated G-proteins if they contain a histidine tag, whilst GF/C filters bind all proteins that are not immobilized on the surface of Ni-NTA beads.

Figure 5.  Reconstitution of α2A-AR with Gαi1his + Gβ1γ2 in suspension. 20 nM of both Gαi1his and Gβ1γ2 were combined with 0.1 mg/ml of α2A-AR membranes, 5 µM GDP, 10 µM AMP-PNP (‘reconstitution mix’), 0.2 nM [35S]GTPγS and 100 µM yohimbine (where shown) in TMND buffer. The reaction was started with 10 µM UK14304 (final) and the reaction was incubated for 90 min at 27°C with shaking. Final volume was 100 µl. The entire reaction was filtered over a filter ‘stack’ that was comprised of a Whatman #1 paper filter on top of a GF/C filter. The sample was washed with 3×4 ml with ice-cold TMN buffer. (A) The Whatman #1 filter data set and (B) GF/C filter data set were counted (by scintillation) separately (n=3, mean±SEM). Abbreviations; UK, UK14304, Yoh, yohimbine.

Figure 5.  Reconstitution of α2A-AR with Gαi1his + Gβ1γ2 in suspension. 20 nM of both Gαi1his and Gβ1γ2 were combined with 0.1 mg/ml of α2A-AR membranes, 5 µM GDP, 10 µM AMP-PNP (‘reconstitution mix’), 0.2 nM [35S]GTPγS and 100 µM yohimbine (where shown) in TMND buffer. The reaction was started with 10 µM UK14304 (final) and the reaction was incubated for 90 min at 27°C with shaking. Final volume was 100 µl. The entire reaction was filtered over a filter ‘stack’ that was comprised of a Whatman #1 paper filter on top of a GF/C filter. The sample was washed with 3×4 ml with ice-cold TMN buffer. (A) The Whatman #1 filter data set and (B) GF/C filter data set were counted (by scintillation) separately (n=3, mean±SEM). Abbreviations; UK, UK14304, Yoh, yohimbine.

Figure 6.  α2A-AR-activated [35S]GTPγS:G-protein subunit dissociation. (A), Ni2 + -bead capture of α2A-AR-activated [35S]GTPγS:Gαi1his. 20 nM of both Gαi1his and Gβ1γ2 were used and (B), α2A-AR-activated [35S]GTPγS:Gαi11γ2his dissociation. 20 nM of both Gαi1 and β1γ2his were used. In both (A) and (B) the appropriate combination of G-proteins were combined with 0.1 mg/ml of α2A-AR membranes and 5 µM GDP and 10 µM AMP-PNP (‘reconstitution mix’), 0.2 nM [35S]GTPγS, 100 µM Yohimbine or 100 mM imidazole (where shown) in TMND buffer. 10 µl of Ni(NTA) agarose beads were added to the reconstitution mix and the reaction was started with 10 µM UK14304 [final]. The mix was incubated for 90 min at 27°C with shaking. Final volume was 100 µl. The entire reaction was filtered over a ‘filter stack’ that was comprised of a Whatman #1 filter paper on top with a GF/C filter beneath it. The bead sample was washed with 3×4 ml with ice-cold TMN buffer. Whatman #1 paper filters and GF/C filters were counted (scintillation) separately as indicated (n=3, mean±SEM). Abbreviations; UK, UK14304.

Figure 6.  α2A-AR-activated [35S]GTPγS:G-protein subunit dissociation. (A), Ni2 + -bead capture of α2A-AR-activated [35S]GTPγS:Gαi1his. 20 nM of both Gαi1his and Gβ1γ2 were used and (B), α2A-AR-activated [35S]GTPγS:Gαi1/β1γ2his dissociation. 20 nM of both Gαi1 and β1γ2his were used. In both (A) and (B) the appropriate combination of G-proteins were combined with 0.1 mg/ml of α2A-AR membranes and 5 µM GDP and 10 µM AMP-PNP (‘reconstitution mix’), 0.2 nM [35S]GTPγS, 100 µM Yohimbine or 100 mM imidazole (where shown) in TMND buffer. 10 µl of Ni(NTA) agarose beads were added to the reconstitution mix and the reaction was started with 10 µM UK14304 [final]. The mix was incubated for 90 min at 27°C with shaking. Final volume was 100 µl. The entire reaction was filtered over a ‘filter stack’ that was comprised of a Whatman #1 filter paper on top with a GF/C filter beneath it. The bead sample was washed with 3×4 ml with ice-cold TMN buffer. Whatman #1 paper filters and GF/C filters were counted (scintillation) separately as indicated (n=3, mean±SEM). Abbreviations; UK, UK14304.

Figure 7.  Schematic demonstrating the specificity of the ‘filter stack’. Following α2A-AR-stimulated G-protein activation, as measured by [35S]GTPγS binding to Gα subunits, the reaction mixture is filtered over a ‘filter stack’ comprising a top layer of Whatman #1 filter paper (to collect Ni2 + -coated (Ni(NTA)) agarose beads containing hexahistidine-tagged G-proteins), with a GF/C directly beneath it (to collect G-proteins that are not captured by the Ni(NTA) agarose). (A), The [35S]GTPγS bound to Gαi1his is attached to the Ni(NTA) bead via the heaxahistidine-Ni2 +  interaction, and is thus retained on the upper Whatman #1 filter in the stack. (B), Following α2A-AR-stimulated G-protein activation using Gαi1 and β1γ2his, the activated Gαi1:[35S]GTPγS complex is not retained on the Ni(NTA) beads but is captured by the GF/C filter.

Figure 7.  Schematic demonstrating the specificity of the ‘filter stack’. Following α2A-AR-stimulated G-protein activation, as measured by [35S]GTPγS binding to Gα subunits, the reaction mixture is filtered over a ‘filter stack’ comprising a top layer of Whatman #1 filter paper (to collect Ni2 + -coated (Ni(NTA)) agarose beads containing hexahistidine-tagged G-proteins), with a GF/C directly beneath it (to collect G-proteins that are not captured by the Ni(NTA) agarose). (A), The [35S]GTPγS bound to Gαi1his is attached to the Ni(NTA) bead via the heaxahistidine-Ni2 +  interaction, and is thus retained on the upper Whatman #1 filter in the stack. (B), Following α2A-AR-stimulated G-protein activation using Gαi1 and β1γ2his, the activated Gαi1:[35S]GTPγS complex is not retained on the Ni(NTA) beads but is captured by the GF/C filter.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.